CRO LLC

CRO LLC specializes in the manufacturing of biological products excluding diagnostics, with demonstrated expertise in producing specialized formulations for international diplomatic missions. Their technical capabilities center on aseptic processing, cold-chain logistics, and regulatory-compliant production of biologics under Good Manufacturing Practices (GMP), tailored to meet U.S. State Department requirements for overseas medical support. The company’s focus on polyserum products suggests deep familiarity with immunoglobulin-based therapeutics and blood-derived biologics, requiring stringent quality control, stability testing, and compliance with FDA and international pharmacopeial standards. Their ability to deliver mission-critical biological supplies under tight operational timelines reflects a niche specialization in rapid-response biomanufacturing for diplomatic health security. CRO LLC has established a direct working relationship with the Department of State, providing biologics essential for the health and operational readiness of U.S. diplomatic personnel abroad. The most recent award for the U.S. Mission in Mexico underscores a pattern of mission-specific, just-in-time delivery of life-sustaining biological products, indicating a trusted, low-volume but high-impact partnership focused on emergency preparedness and medical contingency support. The contractor’s primary industry focus is biological product manufacturing (NAICS 325414), a highly regulated vertical requiring validated processes, environmental monitoring, and batch traceability. This positions CRO LLC within the niche segment of non-diagnostic biologics supply for government and diplomatic applications, distinguishing them from large-scale pharmaceutical manufacturers by emphasizing agility, regulatory precision, and mission alignment over commercial volume. CRO LLC is a Service-Disabled Veteran-Owned Business structured as a small business (2L), headquartered in Missoula, Montana. Their certification under the VA’s SDVOSB program affirms their eligibility for set-aside contracts and reflects a commitment to veteran-led innovation in federal biomanufacturing. While geographically concentrated, their operational reach extends globally through mission-critical supply chains supporting U.S. diplomatic infrastructure.